Clinical trial
Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®
NCT00475553 · Scott and White Hospital & Clinic, Other · Completed
Key facts
| NCT number | NCT00475553 |
|---|---|
| Title | Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing® |
| Official title | The Frequency and Management of Breakthrough Bleeding During Extended Therapy With the Transvaginal Contraceptive Ring |
| Lead sponsor | Scott and White Hospital & Clinic, Other |
| Collaborators | Organon Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breakthrough Bleeding, Breakthrough Spotting |
| Intervention type | Other |
| Interventions | remove ring if bleeding or spotting occurs more than 5 days, If bleeding does not remove ring |
| Enrollment | 75 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | May 21, 2007 |
| Last update posted | Dec 18, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: